Skip to main content

Published locations for Commentary: HER2+-targeted therapy, ovarian suppression, and adjuvant therapy in breast cancer, February 2023

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Commentary: HER2+-targeted therapy, ovarian suppression, and adjuvant therapy in breast cancer, February 2023

User login

  • Reset your password
  • /content/commentary-her2-targeted-therapy-ovarian-suppression-and-adjuvant-therapy-breast-cancer
  • /hematology-oncology/article/260902/breast-cancer/commentary-her2-targeted-therapy-ovarian